Interestingly, in the same study, SDMA levels were independently related to plasma levels of neurofilament light chain (NF-L) [151], an axonal cytoskeletal protein that acts as a biomarker for neurodegeneration and has previously been shown to relate to Alzheimer’s disease pathology and cognitive dysfunction [152]. This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.